CA2348689C - Techniques combinees pour la synthese de polymeres - Google Patents

Techniques combinees pour la synthese de polymeres Download PDF

Info

Publication number: CA2348689C
Authority: CA; Canada
Prior art keywords: support; array; dispenser; different; localized areas
Prior art date: 1991-11-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002348689A

Other languages

English (en)

Other versions

CA2348689A1 (fr

Inventor

James L. Winkler

Stephen P.A. Fodor

Christopher J. Buchko

Debra A. Ross

Lois Aldwin

Douglas N. Modlin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Affymetrix Inc

Original Assignee

Affymetrix Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-22

Filing date

1992-11-20

Publication date

2005-08-09

1991-11-22 Priority claimed from US07/796,243 external-priority patent/US5384261A/en

1992-04-24 Priority claimed from US07/874,849 external-priority patent/US5412087A/en

1992-11-20 Application filed by Affymetrix Inc filed Critical Affymetrix Inc

1992-11-20 Priority claimed from CA002124087A external-priority patent/CA2124087C/fr

1993-05-27 Publication of CA2348689A1 publication Critical patent/CA2348689A1/fr

2005-08-09 Application granted granted Critical

2005-08-09 Publication of CA2348689C publication Critical patent/CA2348689C/fr

2012-11-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

229920000642 polymer Polymers 0.000 title claims abstract description 123
230000015572 biosynthetic process Effects 0.000 title description 49
238000003786 synthesis reaction Methods 0.000 title description 47
239000000758 substrate Substances 0.000 claims abstract description 274
238000000034 method Methods 0.000 claims abstract description 265
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 56
239000000178 monomer Substances 0.000 claims description 138
239000000243 solution Substances 0.000 claims description 78
150000001875 compounds Chemical class 0.000 claims description 68
150000007523 nucleic acids Chemical class 0.000 claims description 56
108020004707 nucleic acids Proteins 0.000 claims description 55
102000039446 nucleic acids Human genes 0.000 claims description 55
108090000765 processed proteins & peptides Proteins 0.000 claims description 54
102000004196 processed proteins & peptides Human genes 0.000 claims description 42
108020003175 receptors Proteins 0.000 claims description 40
102000005962 receptors Human genes 0.000 claims description 40
239000000463 material Substances 0.000 claims description 36
239000012530 fluid Substances 0.000 claims description 28
150000001413 amino acids Chemical class 0.000 claims description 26
229920001184 polypeptide Polymers 0.000 claims description 24
239000011521 glass Substances 0.000 claims description 18
230000002209 hydrophobic effect Effects 0.000 claims description 18
-1 sheets Substances 0.000 claims description 17
108091034117 Oligonucleotide Proteins 0.000 claims description 15
239000000284 extract Substances 0.000 claims description 14
239000000126 substance Substances 0.000 claims description 14
239000010703 silicon Substances 0.000 claims description 13
229910052710 silicon Inorganic materials 0.000 claims description 13
239000007787 solid Substances 0.000 claims description 13
108090000790 Enzymes Proteins 0.000 claims description 8
102000004190 Enzymes Human genes 0.000 claims description 8
239000004417 polycarbonate Substances 0.000 claims description 8
238000004891 communication Methods 0.000 claims description 7
239000000499 gel Substances 0.000 claims description 7
229920000515 polycarbonate Polymers 0.000 claims description 7
239000010453 quartz Substances 0.000 claims description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
108091008039 hormone receptors Proteins 0.000 claims description 5
239000008188 pellet Substances 0.000 claims description 5
239000005297 pyrex Substances 0.000 claims description 5
102000003840 Opioid Receptors Human genes 0.000 claims description 4
108090000137 Opioid Receptors Proteins 0.000 claims description 4
239000004952 Polyamide Substances 0.000 claims description 4
239000004793 Polystyrene Substances 0.000 claims description 4
239000011324 bead Substances 0.000 claims description 4
230000003197 catalytic effect Effects 0.000 claims description 4
230000003287 optical effect Effects 0.000 claims description 4
230000003204 osmotic effect Effects 0.000 claims description 4
229920002120 photoresistant polymer Polymers 0.000 claims description 4
229920002647 polyamide Polymers 0.000 claims description 4
108091033319 polynucleotide Proteins 0.000 claims description 4
102000040430 polynucleotide Human genes 0.000 claims description 4
239000002157 polynucleotide Substances 0.000 claims description 4
229920002223 polystyrene Polymers 0.000 claims description 4
229920002873 Polyethylenimine Polymers 0.000 claims description 3
229920002396 Polyurea Polymers 0.000 claims description 3
239000012620 biological material Substances 0.000 claims description 3
230000000994 depressogenic effect Effects 0.000 claims description 3
239000002245 particle Substances 0.000 claims description 3
229920000728 polyester Polymers 0.000 claims description 3
239000002244 precipitate Substances 0.000 claims description 3
239000002773 nucleotide Substances 0.000 claims description 2
125000003729 nucleotide group Chemical group 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims 2
229910010272 inorganic material Inorganic materials 0.000 claims 2
239000011147 inorganic material Substances 0.000 claims 2
239000011368 organic material Substances 0.000 claims 2
229920002635 polyurethane Polymers 0.000 claims 2
239000004814 polyurethane Substances 0.000 claims 2
230000008569 process Effects 0.000 abstract description 20
238000003491 array Methods 0.000 abstract description 15
238000006243 chemical reaction Methods 0.000 description 101
230000008878 coupling Effects 0.000 description 45
238000010168 coupling process Methods 0.000 description 45
238000005859 coupling reaction Methods 0.000 description 45
239000000376 reactant Substances 0.000 description 32
235000001014 amino acid Nutrition 0.000 description 24
230000027455 binding Effects 0.000 description 21
239000011159 matrix material Substances 0.000 description 18
239000003446 ligand Substances 0.000 description 16
125000006239 protecting group Chemical group 0.000 description 15
210000004027 cell Anatomy 0.000 description 14
230000000694 effects Effects 0.000 description 12
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 10
239000007788 liquid Substances 0.000 description 10
238000012216 screening Methods 0.000 description 10
238000012546 transfer Methods 0.000 description 10
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 9
238000005284 basis set Methods 0.000 description 9
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 9
239000002904 solvent Substances 0.000 description 9
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
238000009396 hybridization Methods 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
241000894007 species Species 0.000 description 8
230000002194 synthesizing effect Effects 0.000 description 8
238000005406 washing Methods 0.000 description 8
229940079593 drug Drugs 0.000 description 7
239000003814 drug Substances 0.000 description 7
238000001704 evaporation Methods 0.000 description 7
230000008020 evaporation Effects 0.000 description 7
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
238000000151 deposition Methods 0.000 description 6
125000005647 linker group Chemical group 0.000 description 6
238000000926 separation method Methods 0.000 description 6
125000006850 spacer group Chemical group 0.000 description 6
238000012360 testing method Methods 0.000 description 6
238000013519 translation Methods 0.000 description 6
230000014616 translation Effects 0.000 description 6
235000012431 wafers Nutrition 0.000 description 6
230000004913 activation Effects 0.000 description 5
238000013459 approach Methods 0.000 description 5
238000010586 diagram Methods 0.000 description 5
238000013507 mapping Methods 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
239000012528 membrane Substances 0.000 description 5
239000000203 mixture Substances 0.000 description 5
239000007790 solid phase Substances 0.000 description 5
238000009736 wetting Methods 0.000 description 5
229910052782 aluminium Inorganic materials 0.000 description 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
239000000539 dimer Substances 0.000 description 4
239000010410 layer Substances 0.000 description 4
230000033001 locomotion Effects 0.000 description 4
230000000087 stabilizing effect Effects 0.000 description 4
238000011282 treatment Methods 0.000 description 4
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
238000007792 addition Methods 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
230000008859 change Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
238000010511 deprotection reaction Methods 0.000 description 3
239000000975 dye Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
239000007850 fluorescent dye Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000002356 single layer Substances 0.000 description 3
239000002699 waste material Substances 0.000 description 3
ZPGDWQNBZYOZTI-GOSISDBHSA-N (2r)-1-(9h-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ZPGDWQNBZYOZTI-GOSISDBHSA-N 0.000 description 2
WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102000018997 Growth Hormone Human genes 0.000 description 2
108010051696 Growth Hormone Proteins 0.000 description 2
150000008575 L-amino acids Chemical class 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
239000012190 activator Substances 0.000 description 2
WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
238000003486 chemical etching Methods 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000008021 deposition Effects 0.000 description 2
230000005684 electric field Effects 0.000 description 2
238000005530 etching Methods 0.000 description 2
238000011049 filling Methods 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
239000000122 growth hormone Substances 0.000 description 2
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
125000001165 hydrophobic group Chemical group 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
102000006240 membrane receptors Human genes 0.000 description 2
108020004084 membrane receptors Proteins 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
244000005700 microbiome Species 0.000 description 2
238000005459 micromachining Methods 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
239000002858 neurotransmitter agent Substances 0.000 description 2
239000002777 nucleoside Substances 0.000 description 2
125000003835 nucleoside group Chemical group 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
230000003711 photoprotective effect Effects 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
238000003825 pressing Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
238000012552 review Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000006163 transport media Substances 0.000 description 2
SWZCTMTWRHEBIN-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(O)C=C1 SWZCTMTWRHEBIN-QFIPXVFZSA-N 0.000 description 1
NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
IYAYDWLKTPIEDC-UHFFFAOYSA-N 2-[2-hydroxyethyl(3-triethoxysilylpropyl)amino]ethanol Chemical compound CCO[Si](OCC)(OCC)CCCN(CCO)CCO IYAYDWLKTPIEDC-UHFFFAOYSA-N 0.000 description 1
XCDJMQRPMLFIHY-PZMMFNHRSA-N 2-aminoacetic acid;(2s)-2-amino-4-methylpentanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.CC(C)C[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 XCDJMQRPMLFIHY-PZMMFNHRSA-N 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
241000283707 Capra Species 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
150000008574 D-amino acids Chemical class 0.000 description 1
GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
241000233866 Fungi Species 0.000 description 1
KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
108010022337 Leucine Enkephalin Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004642 Polyimide Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
241000231739 Rutilus rutilus Species 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
NOOMDULIORCDNF-IRXDYDNUSA-N Tyr-Gly-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NOOMDULIORCDNF-IRXDYDNUSA-N 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000556 agonist Substances 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
150000001371 alpha-amino acids Chemical class 0.000 description 1
235000008206 alpha-amino acids Nutrition 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000007806 chemical reaction intermediate Substances 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
238000005229 chemical vapour deposition Methods 0.000 description 1
FDJUMMKAFUMWBI-UHFFFAOYSA-N chloro carbonochloridate Chemical compound ClOC(Cl)=O FDJUMMKAFUMWBI-UHFFFAOYSA-N 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
238000000748 compression moulding Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
229920005565 cyclic polymer Polymers 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
238000010894 electron beam technology Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
235000019441 ethanol Nutrition 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000008713 feedback mechanism Effects 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000013023 gasketing Methods 0.000 description 1
230000005484 gravity Effects 0.000 description 1
229920000140 heteropolymer Polymers 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000005286 illumination Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000013383 initial experiment Methods 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000003698 laser cutting Methods 0.000 description 1
239000002523 lectin Substances 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
238000001459 lithography Methods 0.000 description 1
238000003754 machining Methods 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
238000004377 microelectronic Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000005232 molecular self-assembly Methods 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
238000000465 moulding Methods 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
125000006502 nitrobenzyl group Chemical group 0.000 description 1
239000012454 non-polar solvent Substances 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
229940127240 opiate Drugs 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
150000002972 pentoses Chemical class 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
238000000206 photolithography Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920000412 polyarylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001721 polyimide Polymers 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000000047 product Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
239000011253 protective coating Substances 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000005086 pumping Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000004064 recycling Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000000518 rheometry Methods 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000000565 sealant Substances 0.000 description 1
239000012812 sealant material Substances 0.000 description 1
238000007789 sealing Methods 0.000 description 1
239000002094 self assembled monolayer Substances 0.000 description 1
239000013545 self-assembled monolayer Substances 0.000 description 1
239000004065 semiconductor Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
150000004763 sulfides Chemical class 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000005062 synaptic transmission Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000006257 total synthesis reaction Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
239000013638 trimer Substances 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
239000012808 vapor phase Substances 0.000 description 1
230000003639 vasoconstrictive effect Effects 0.000 description 1
231100000611 venom Toxicity 0.000 description 1
239000002435 venom Substances 0.000 description 1
210000001048 venom Anatomy 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Apparatus Associated With Microorganisms And Enzymes (AREA)
Physical Or Chemical Processes And Apparatus (AREA)

CA002348689A 1991-11-22 1992-11-20 Techniques combinees pour la synthese de polymeres Expired - Fee Related CA2348689C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US07/796,243 US5384261A (en)	1991-11-22	1991-11-22	Very large scale immobilized polymer synthesis using mechanically directed flow paths
US07/796,243		1991-11-22
US07/874,849		1992-04-24
US07/874,849 US5412087A (en)	1992-04-24	1992-04-24	Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
CA002124087A CA2124087C (fr)	1991-11-22	1992-11-20	Techniques combinees pour la synthese de polymeres

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002124087A Division CA2124087C (fr)	1991-11-22	1992-11-20	Techniques combinees pour la synthese de polymeres

Publications (2)

Publication Number	Publication Date
CA2348689A1 CA2348689A1 (fr)	1993-05-27
CA2348689C true CA2348689C (fr)	2005-08-09

Family

ID=27169779

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA002348689A Expired - Fee Related CA2348689C (fr)	1991-11-22	1992-11-20	Techniques combinees pour la synthese de polymeres
CA002389355A Abandoned CA2389355A1 (fr)	1991-11-22	1992-11-20	Techniques combinees pour la synthese de polymeres

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA002389355A Abandoned CA2389355A1 (fr)	1991-11-22	1992-11-20	Techniques combinees pour la synthese de polymeres

Country Status (1)

Country	Link
CA (2)	CA2348689C (fr)

1992
- 1992-11-20 CA CA002348689A patent/CA2348689C/fr not_active Expired - Fee Related
- 1992-11-20 CA CA002389355A patent/CA2389355A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
CA2389355A1 (fr)	1993-05-27
CA2348689A1 (fr)	1993-05-27

Legal Events

Date	Code	Title	Description
2001-11-13	EEER	Examination request
2010-11-22	MKLA	Lapsed

Publication	Publication Date	Title
CA2124087C (fr)	2002-10-01	Techniques combinees pour la synthese de polymeres
US7736906B2 (en)	2010-06-15	Combinatorial strategies for polymer synthesis
US6864101B1 (en)	2005-03-08	Combinatorial strategies for polymer synthesis
US5885837A (en)	1999-03-23	Very large scale immobilized polymer synthesis using mechanically directed flow paths
AU651795B2 (en)	1994-08-04	Very large scale immobilized polymer synthesis
US20020119578A1 (en)	2002-08-29	Guided deposition in spatial arrays
CA2348689C (fr)	2005-08-09	Techniques combinees pour la synthese de polymeres
HK1025278B (en)	2003-10-03	Method of forming arrays of polymers
HK1019883A (en)	2000-03-03	Very large scale immobilized peptide synthesis
HK1023618A (en)	2000-09-15	Apparatus for detection of a fluorescence pattern corresponding to ligand binding on a substrate